 Gregory Austin
Concepts (272)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proton Pump Inhibitors | 7 | 2018 | 98 | 2.920 |
Why?
| | Adenoma | 9 | 2022 | 215 | 2.750 |
Why?
| | Gastric Bypass | 6 | 2017 | 107 | 2.590 |
Why?
| | Colonoscopy | 10 | 2022 | 234 | 2.510 |
Why?
| | Colorectal Neoplasms | 10 | 2022 | 753 | 2.190 |
Why?
| | Obesity, Morbid | 6 | 2017 | 238 | 1.920 |
Why?
| | Energy Intake | 6 | 2015 | 455 | 1.520 |
Why?
| | Intestines | 3 | 2017 | 349 | 1.190 |
Why?
| | Weight Loss | 5 | 2017 | 724 | 1.150 |
Why?
| | Gastric Acid | 3 | 2015 | 14 | 1.030 |
Why?
| | Gastroesophageal Reflux | 3 | 2015 | 232 | 1.010 |
Why?
| | Laparoscopy | 5 | 2017 | 454 | 0.960 |
Why?
| | Postoperative Care | 2 | 2015 | 243 | 0.840 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2017 | 521 | 0.820 |
Why?
| | Colonic Polyps | 2 | 2021 | 87 | 0.810 |
Why?
| | Medicaid | 2 | 2016 | 437 | 0.730 |
Why?
| | Body Mass Index | 7 | 2018 | 2266 | 0.730 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2021 | 58 | 0.700 |
Why?
| | Diet | 5 | 2015 | 1204 | 0.700 |
Why?
| | Education | 1 | 2020 | 100 | 0.660 |
Why?
| | Conscious Sedation | 1 | 2020 | 84 | 0.630 |
Why?
| | Microbiota | 4 | 2017 | 720 | 0.630 |
Why?
| | Research Personnel | 1 | 2020 | 160 | 0.600 |
Why?
| | Mentors | 1 | 2020 | 180 | 0.590 |
Why?
| | Bariatric Surgery | 1 | 2021 | 192 | 0.590 |
Why?
| | Diet, Carbohydrate-Restricted | 2 | 2009 | 32 | 0.570 |
Why?
| | Triage | 1 | 2020 | 213 | 0.570 |
Why?
| | Mentoring | 1 | 2020 | 131 | 0.560 |
Why?
| | Obesity | 5 | 2015 | 2863 | 0.560 |
Why?
| | Early Detection of Cancer | 5 | 2022 | 372 | 0.550 |
Why?
| | Nutrition Surveys | 5 | 2018 | 262 | 0.530 |
Why?
| | Middle Aged | 32 | 2020 | 31079 | 0.520 |
Why?
| | Gastrectomy | 1 | 2017 | 99 | 0.510 |
Why?
| | Weight Gain | 2 | 2015 | 505 | 0.480 |
Why?
| | Preoperative Care | 1 | 2016 | 342 | 0.440 |
Why?
| | Cardiovascular Diseases | 2 | 2018 | 2024 | 0.440 |
Why?
| | Antidepressive Agents | 1 | 2015 | 221 | 0.440 |
Why?
| | Dietary Sucrose | 1 | 2013 | 48 | 0.420 |
Why?
| | Midazolam | 1 | 2013 | 48 | 0.420 |
Why?
| | Insurance Coverage | 1 | 2015 | 222 | 0.420 |
Why?
| | Female | 36 | 2020 | 68517 | 0.400 |
Why?
| | Male | 34 | 2020 | 63201 | 0.400 |
Why?
| | Fentanyl | 1 | 2013 | 80 | 0.400 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2018 | 566 | 0.400 |
Why?
| | Insulin Resistance | 2 | 2018 | 1167 | 0.390 |
Why?
| | Inflammatory Bowel Diseases | 2 | 2007 | 312 | 0.390 |
Why?
| | Polyethylene Glycols | 1 | 2017 | 597 | 0.390 |
Why?
| | Humans | 48 | 2022 | 129126 | 0.390 |
Why?
| | Adult | 26 | 2020 | 35512 | 0.380 |
Why?
| | Dietary Fats | 1 | 2013 | 301 | 0.370 |
Why?
| | Motor Activity | 2 | 2015 | 669 | 0.370 |
Why?
| | Medicare | 1 | 2016 | 724 | 0.350 |
Why?
| | Education, Medical | 2 | 2013 | 245 | 0.350 |
Why?
| | Length of Stay | 2 | 2015 | 1123 | 0.340 |
Why?
| | Aged | 15 | 2020 | 22089 | 0.320 |
Why?
| | Patient Readmission | 1 | 2015 | 668 | 0.320 |
Why?
| | Irritable Bowel Syndrome | 1 | 2009 | 28 | 0.310 |
Why?
| | Ethanol | 1 | 2013 | 585 | 0.310 |
Why?
| | Predictive Value of Tests | 6 | 2020 | 1943 | 0.310 |
Why?
| | Intestinal Mucosa | 4 | 2018 | 579 | 0.310 |
Why?
| | Diarrhea | 1 | 2009 | 177 | 0.290 |
Why?
| | Inflammation | 1 | 2018 | 2668 | 0.280 |
Why?
| | Serologic Tests | 1 | 2007 | 50 | 0.280 |
Why?
| | Dysbiosis | 3 | 2017 | 169 | 0.270 |
Why?
| | Health Services Research | 1 | 2010 | 389 | 0.270 |
Why?
| | Retrospective Studies | 12 | 2017 | 14571 | 0.270 |
Why?
| | Fellowships and Scholarships | 1 | 2010 | 274 | 0.260 |
Why?
| | Family | 1 | 2011 | 648 | 0.260 |
Why?
| | Fruit | 1 | 2007 | 131 | 0.260 |
Why?
| | Meat | 1 | 2007 | 93 | 0.260 |
Why?
| | Colon | 3 | 2018 | 251 | 0.260 |
Why?
| | Lymphocyte Activation | 4 | 2017 | 1098 | 0.250 |
Why?
| | Alcohol Drinking | 2 | 2013 | 751 | 0.240 |
Why?
| | HIV Infections | 5 | 2018 | 2715 | 0.240 |
Why?
| | Exercise | 1 | 2015 | 1950 | 0.220 |
Why?
| | Practice Patterns, Physicians' | 1 | 2012 | 1269 | 0.220 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 4 | 2016 | 206 | 0.220 |
Why?
| | Young Adult | 9 | 2020 | 12389 | 0.210 |
Why?
| | Time Factors | 6 | 2017 | 6518 | 0.210 |
Why?
| | Mass Screening | 1 | 2011 | 1159 | 0.210 |
Why?
| | Aging | 1 | 2013 | 1772 | 0.210 |
Why?
| | United States | 6 | 2018 | 13939 | 0.190 |
Why?
| | Cohort Studies | 3 | 2017 | 5407 | 0.190 |
Why?
| | Liver Transplantation | 2 | 2011 | 799 | 0.190 |
Why?
| | Gastric Acidity Determination | 2 | 2014 | 7 | 0.190 |
Why?
| | Risk Factors | 8 | 2020 | 9768 | 0.180 |
Why?
| | Cross-Sectional Studies | 5 | 2018 | 5070 | 0.180 |
Why?
| | Age Factors | 2 | 2020 | 3120 | 0.180 |
Why?
| | HIV-1 | 3 | 2017 | 842 | 0.170 |
Why?
| | Adenomatous Polyps | 1 | 2020 | 10 | 0.170 |
Why?
| | Blood Component Transfusion | 2 | 2011 | 79 | 0.170 |
Why?
| | Smoking | 1 | 2007 | 1466 | 0.170 |
Why?
| | Treatment Outcome | 6 | 2017 | 10226 | 0.160 |
Why?
| | Iron | 1 | 2021 | 283 | 0.160 |
Why?
| | Biomarkers | 4 | 2018 | 3896 | 0.160 |
Why?
| | Case-Control Studies | 5 | 2016 | 3342 | 0.160 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1493 | 0.150 |
Why?
| | Colorado | 4 | 2020 | 4396 | 0.150 |
Why?
| | Follow-Up Studies | 4 | 2014 | 4915 | 0.140 |
Why?
| | Acute Lung Injury | 2 | 2011 | 264 | 0.140 |
Why?
| | Interferon Type I | 1 | 2018 | 140 | 0.140 |
Why?
| | Sex Factors | 2 | 2013 | 1953 | 0.140 |
Why?
| | Leukocytes, Mononuclear | 2 | 2018 | 538 | 0.140 |
Why?
| | Narrow Band Imaging | 2 | 2016 | 14 | 0.140 |
Why?
| | Quality of Life | 1 | 2009 | 2694 | 0.140 |
Why?
| | Guideline Adherence | 1 | 2021 | 525 | 0.140 |
Why?
| | Immunity, Mucosal | 1 | 2017 | 94 | 0.130 |
Why?
| | Solutions | 1 | 2017 | 148 | 0.130 |
Why?
| | Bacterial Translocation | 1 | 2017 | 39 | 0.130 |
Why?
| | Biliary Tract Diseases | 1 | 2016 | 36 | 0.130 |
Why?
| | Genitalia | 1 | 2016 | 30 | 0.130 |
Why?
| | Butyrates | 1 | 2017 | 54 | 0.130 |
Why?
| | Immunologic Factors | 1 | 2018 | 229 | 0.130 |
Why?
| | Pancreatic Diseases | 1 | 2016 | 67 | 0.130 |
Why?
| | Polyethylene | 1 | 2016 | 10 | 0.130 |
Why?
| | Aged, 80 and over | 3 | 2018 | 7065 | 0.130 |
Why?
| | Surveys and Questionnaires | 3 | 2020 | 5377 | 0.130 |
Why?
| | Hernia, Hiatal | 1 | 2016 | 32 | 0.130 |
Why?
| | Esophageal Motility Disorders | 1 | 2016 | 26 | 0.130 |
Why?
| | Esophagogastric Junction | 1 | 2016 | 50 | 0.130 |
Why?
| | Program Evaluation | 1 | 2020 | 876 | 0.120 |
Why?
| | Endosonography | 2 | 2016 | 142 | 0.120 |
Why?
| | Pancreatitis, Chronic | 1 | 2016 | 51 | 0.120 |
Why?
| | Emtricitabine | 1 | 2016 | 168 | 0.120 |
Why?
| | Pancreatic Ducts | 1 | 2016 | 80 | 0.120 |
Why?
| | Rectum | 1 | 2016 | 169 | 0.120 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 1825 | 0.120 |
Why?
| | Dementia | 1 | 2018 | 227 | 0.120 |
Why?
| | Tenofovir | 1 | 2016 | 231 | 0.120 |
Why?
| | Verrucomicrobia | 1 | 2014 | 5 | 0.120 |
Why?
| | Bacteroidetes | 1 | 2014 | 23 | 0.120 |
Why?
| | Proteobacteria | 1 | 2014 | 16 | 0.120 |
Why?
| | Cholangitis, Sclerosing | 2 | 2016 | 70 | 0.120 |
Why?
| | Mucous Membrane | 1 | 2015 | 120 | 0.110 |
Why?
| | Esophagus | 1 | 2016 | 249 | 0.110 |
Why?
| | Diet Records | 1 | 2013 | 80 | 0.110 |
Why?
| | Multivariate Analysis | 2 | 2007 | 1496 | 0.110 |
Why?
| | Anesthetics, Intravenous | 1 | 2013 | 38 | 0.110 |
Why?
| | Polyps | 1 | 2013 | 11 | 0.100 |
Why?
| | Endotoxemia | 1 | 2014 | 84 | 0.100 |
Why?
| | Immunity | 1 | 2014 | 132 | 0.100 |
Why?
| | Dietary Carbohydrates | 1 | 2013 | 152 | 0.100 |
Why?
| | Veterans | 1 | 2004 | 1419 | 0.100 |
Why?
| | Neoplasm Staging | 1 | 2016 | 1293 | 0.100 |
Why?
| | Prevalence | 2 | 2011 | 2564 | 0.100 |
Why?
| | Ambulatory Care | 1 | 2016 | 506 | 0.100 |
Why?
| | Stents | 1 | 2016 | 504 | 0.090 |
Why?
| | Bile Duct Neoplasms | 1 | 2012 | 99 | 0.090 |
Why?
| | Cluster Analysis | 2 | 2017 | 478 | 0.090 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2020 | 1275 | 0.090 |
Why?
| | Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 14 | 0.090 |
Why?
| | Kidney | 1 | 2018 | 1308 | 0.090 |
Why?
| | Gastrointestinal Microbiome | 2 | 2017 | 636 | 0.090 |
Why?
| | C-Reactive Protein | 1 | 2013 | 397 | 0.090 |
Why?
| | Prospective Studies | 4 | 2016 | 7079 | 0.090 |
Why?
| | Gastroenterology | 1 | 2013 | 174 | 0.090 |
Why?
| | Fatty Acids | 1 | 2013 | 415 | 0.090 |
Why?
| | Bacteria | 1 | 2017 | 811 | 0.090 |
Why?
| | Feeding Behavior | 1 | 2015 | 618 | 0.080 |
Why?
| | Anti-HIV Agents | 1 | 2016 | 748 | 0.080 |
Why?
| | Adolescent | 4 | 2018 | 20301 | 0.080 |
Why?
| | Colitis, Ulcerative | 1 | 2011 | 114 | 0.080 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 582 | 0.080 |
Why?
| | Pancreatitis | 1 | 2010 | 128 | 0.080 |
Why?
| | Health Care Costs | 1 | 2012 | 395 | 0.080 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2010 | 120 | 0.080 |
Why?
| | Reference Values | 1 | 2011 | 780 | 0.080 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2015 | 847 | 0.080 |
Why?
| | Pancreatic Neoplasms | 2 | 2016 | 878 | 0.080 |
Why?
| | Erythrocyte Transfusion | 1 | 2011 | 182 | 0.080 |
Why?
| | Cross Infection | 1 | 2011 | 196 | 0.080 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2015 | 1048 | 0.080 |
Why?
| | Patient Discharge | 1 | 2015 | 857 | 0.070 |
Why?
| | Regression Analysis | 1 | 2011 | 984 | 0.070 |
Why?
| | Crohn Disease | 1 | 2011 | 211 | 0.070 |
Why?
| | Linoleic Acids, Conjugated | 1 | 2007 | 5 | 0.070 |
Why?
| | North Carolina | 1 | 2007 | 100 | 0.070 |
Why?
| | Antibodies, Fungal | 1 | 2006 | 9 | 0.060 |
Why?
| | Porins | 1 | 2006 | 12 | 0.060 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 2006 | 34 | 0.060 |
Why?
| | Prognosis | 3 | 2011 | 3788 | 0.060 |
Why?
| | Intensive Care Units | 1 | 2010 | 719 | 0.060 |
Why?
| | Antibodies, Bacterial | 1 | 2006 | 136 | 0.060 |
Why?
| | Immunity, Innate | 1 | 2011 | 805 | 0.060 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2006 | 538 | 0.060 |
Why?
| | Life Style | 1 | 2007 | 460 | 0.060 |
Why?
| | Immunoglobulin A | 1 | 2006 | 202 | 0.060 |
Why?
| | Liver Failure | 1 | 2004 | 91 | 0.050 |
Why?
| | Body Composition | 1 | 2007 | 657 | 0.050 |
Why?
| | External Fixators | 2 | 1999 | 16 | 0.050 |
Why?
| | Biopsy | 2 | 2018 | 1086 | 0.050 |
Why?
| | Viral Load | 2 | 2015 | 450 | 0.050 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2006 | 378 | 0.050 |
Why?
| | Diagnosis, Differential | 1 | 2006 | 1417 | 0.050 |
Why?
| | Immunoglobulin G | 1 | 2006 | 846 | 0.050 |
Why?
| | Hepatitis C | 1 | 2004 | 234 | 0.050 |
Why?
| | Incidence | 1 | 2007 | 2635 | 0.040 |
Why?
| | Range of Motion, Articular | 2 | 1999 | 388 | 0.040 |
Why?
| | Survival Rate | 1 | 2004 | 1875 | 0.040 |
Why?
| | Colles' Fracture | 1 | 1999 | 2 | 0.040 |
Why?
| | Fracture Healing | 1 | 1999 | 77 | 0.040 |
Why?
| | Wrist Joint | 1 | 1999 | 63 | 0.040 |
Why?
| | Radius Fractures | 1 | 1999 | 58 | 0.040 |
Why?
| | Fracture Fixation | 1 | 1999 | 82 | 0.040 |
Why?
| | Health Literacy | 1 | 2020 | 162 | 0.040 |
Why?
| | DNA, Ribosomal | 1 | 2017 | 82 | 0.030 |
Why?
| | Choledochal Cyst | 1 | 2016 | 16 | 0.030 |
Why?
| | Biliary Tract Neoplasms | 1 | 2016 | 25 | 0.030 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2016 | 29 | 0.030 |
Why?
| | Risk Assessment | 2 | 2020 | 3260 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2016 | 229 | 0.030 |
Why?
| | Manometry | 1 | 2016 | 91 | 0.030 |
Why?
| | Spermatozoa | 1 | 2016 | 91 | 0.030 |
Why?
| | Video Recording | 1 | 2016 | 164 | 0.030 |
Why?
| | DNA, Bacterial | 1 | 2017 | 324 | 0.030 |
Why?
| | Endoscopy, Digestive System | 1 | 2016 | 122 | 0.030 |
Why?
| | Ruminococcus | 1 | 2015 | 9 | 0.030 |
Why?
| | Prevotella | 1 | 2015 | 14 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2016 | 269 | 0.030 |
Why?
| | Antigens, CD1 | 1 | 2015 | 58 | 0.030 |
Why?
| | Colitis | 1 | 2017 | 240 | 0.030 |
Why?
| | Patient Education as Topic | 1 | 2020 | 736 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2022 | 976 | 0.030 |
Why?
| | Immunoglobulins | 1 | 2015 | 157 | 0.030 |
Why?
| | CD40 Antigens | 1 | 2015 | 88 | 0.030 |
Why?
| | Feces | 1 | 2017 | 437 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2017 | 773 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2017 | 1142 | 0.030 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2016 | 266 | 0.030 |
Why?
| | CD4 Lymphocyte Count | 1 | 2014 | 267 | 0.030 |
Why?
| | Cell Lineage | 1 | 2015 | 334 | 0.030 |
Why?
| | Histocytochemistry | 1 | 2013 | 81 | 0.030 |
Why?
| | Glycoproteins | 1 | 2015 | 337 | 0.030 |
Why?
| | Phylogeny | 1 | 2017 | 846 | 0.030 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 466 | 0.030 |
Why?
| | Pilot Projects | 1 | 2017 | 1567 | 0.030 |
Why?
| | Antigens, CD | 1 | 2015 | 483 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2015 | 762 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2015 | 479 | 0.020 |
Why?
| | Phenotype | 1 | 2020 | 3058 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2014 | 410 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1689 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2267 | 0.020 |
Why?
| | Granulocytes | 1 | 2011 | 79 | 0.020 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 147 | 0.020 |
Why?
| | Biodiversity | 1 | 2014 | 373 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2016 | 1036 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 513 | 0.020 |
Why?
| | ROC Curve | 1 | 2011 | 502 | 0.020 |
Why?
| | STAT3 Transcription Factor | 1 | 2011 | 190 | 0.020 |
Why?
| | Down-Regulation | 1 | 2011 | 634 | 0.020 |
Why?
| | Odds Ratio | 1 | 2011 | 1025 | 0.020 |
Why?
| | Cadaver | 2 | 1999 | 330 | 0.020 |
Why?
| | Rest | 1 | 2007 | 123 | 0.020 |
Why?
| | Phosphorylation | 1 | 2011 | 1687 | 0.020 |
Why?
| | Hospital Mortality | 1 | 2011 | 844 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2508 | 0.020 |
Why?
| | Logistic Models | 1 | 2011 | 1979 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 2007 | 197 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2007 | 758 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2011 | 2676 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2011 | 2739 | 0.010 |
Why?
| | Body Weight | 1 | 2007 | 932 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2007 | 1865 | 0.010 |
Why?
| | Signal Transduction | 1 | 2015 | 4838 | 0.010 |
Why?
| | Energy Metabolism | 1 | 2007 | 836 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1999 | 172 | 0.010 |
Why?
| | Bone Wires | 1 | 1999 | 24 | 0.010 |
Why?
| | Weight-Bearing | 1 | 1999 | 183 | 0.010 |
Why?
| | Osteotomy | 1 | 1999 | 164 | 0.010 |
Why?
| | Biomechanical Phenomena | 1 | 1999 | 780 | 0.010 |
Why?
| | Models, Biological | 1 | 1999 | 1695 | 0.010 |
Why?
|
|
Austin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|